MASTIJET FORT
MASTIJET FORT
Authorised
- Prednisolone
- Bacitracin
- Neomycin
- Tetracycline hydrochloride
Product identification
Medicine name:
MASTIJET FORT
Active substance:
- Prednisolone
- Bacitracin
- Neomycin
- Tetracycline hydrochloride
Target species:
-
Cattle
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Prednisolone10.00/milligram(s)1.00Syringe
-
Bacitracin2000.00/international unit(s)1.00Syringe
-
Neomycin250.00/milligram(s)1.00Syringe
-
Tetracycline hydrochloride200.00/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle
-
Meat and offal14day
-
Milkno withdrawal periodМляко: 8 издоявания.
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51RV01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Bulgaria
Available in:
-
Bulgaria
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intos B.V.
Responsible authority:
- Bulgarian Food Safety Authority
Authorisation number:
- 0022-2008
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 17/10/2023
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Bulgarian (PDF)
Published on: 17/10/2023